What is Kestra Medical Technologies, Ltd.'s (KMTS) StockRank?

MoatMap's StockRank for Kestra Medical Technologies, Ltd. (KMTS) is 21/100, with a Sell signal. This is a composite score combining Quality (29), Value (25), and Momentum (52) factor ranks across MoatMap's 20,000+ stock universe.

Does Kestra Medical Technologies, Ltd. have an economic moat?

Kestra Medical Technologies, Ltd. (KMTS) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Kestra Medical Technologies, Ltd. a buy, hold, or sell?

MoatMap's current signal for Kestra Medical Technologies, Ltd. (KMTS) is Sell, based on a StockRank of 21/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Kestra Medical Technologies, Ltd. in?

Kestra Medical Technologies, Ltd. (KMTS) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

KMTS

SELL

Kestra Medical Technologies, Ltd. · Healthcare · United States · $1.2B · Avg Vol: $9M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-56.6%

D/E

0.2x

Dividend %

—

COMPANY DESCRIPTION

Kestra Medical Technologies specializes in the development and commercialization of wearable medical devices, primarily focusing on cardiac care and remote patient monitoring. The company aims to improve patient outcomes and comfort through its innovative, discreet, and easy-to-use technology. Kestra targets a niche in personalized, preventative, and responsive cardiac management solutions.

FINANCIAL SUMMARY (USD)

Year	2021	2023	2024	2025	CAGR	TTM	2027E	2028E	Fwd CAGR
Revenue	0	7.6M	27.8M	59.8M	180.0%	95.1M	86.2M	121.8M	26.7%
EPS	-1.71	-4.36	-5.07	-5.13	—	-2.43	-2.31	-2.02	—
Shares	49.5M	49.5M	49.5M	51.3M	+3.7%	58.6M	—	—	—
Debt	22.8M	39.1M	45.2M	44.3M	18.0%	46.8M	—	—	—
Equity	1.8M	-117.6M	-209.4M	205.4M	228.4%	—	—	—	—
Op CF	-29.9M	-69.6M	-72.2M	-77.6M	—	-81.7M	—	—	—
Inv CF	-0.3M	-15.5M	-12.2M	-23.3M	—	—	—	—	—
Fin CF	48.8M	96.1M	77.7M	330.3M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+4.6%

SMA 50SMA 200

$21.06

RSI (14)

15.7

52W High

$30.00

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

-40.2%18.8

ROE

-56.6%16.4

GP/Assets

13.6%33.8

Op. Margin

-137.4%15.8

FCF/Assets

-32.7%9.4

Piotroski

550.0

Int. Cover

-16.4x19.6

D/E Ratio

0.18x52.7

Current Ratio

4.41x67.1

Value

P/E (TTM)

—N/A

EV/EBITDA

-9.6x25.0

P/FCF

—N/A

P/B

5.2x25.9

P/S

14.3x21.2

Div Yield

—N/A

Momentum

52W High %

70%54.5

RS 6M

-23%44.3

SMA 50/200

0.94x52.1

EPS Rev 4W

+5.6%93.9

EPS Rev 12W

+5.6%80.1

EPS Improve

+17%32.6

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$1.2B

P/E (Forward)

-11.5x

Gross Margin

51.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of KMTS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
KMTS	Kestra Medical Technologies, Ltd.(you)	$1.2B	21	SELL
PLSE	Pulse Biosciences, Inc.	$2.1B	22	SELL
AZTA	Azenta, Inc.	$1.3B	44	HOLD
ATRC	AtriCure, Inc.	$1.8B	48	HOLD
STAA	STAAR Surgical Company	$1.2B	56	HOLD
WRBY	Warby Parker Inc.	$3.0B	41	HOLD
BLFS	BioLife Solutions, Inc.	$1.5B	56	HOLD
MMED	MiniMed Group, Inc.	$4.7B	37	HOLD
KRMD	KORU Medical Systems, Inc.	$176M	26	SELL
MBOT	Microbot Medical Inc.	$115M	18	STRONG SELL

Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.5%

Kestra Medical Technologies, Ltd. (KMTS) — Stock Score Summary

Kestra Medical Technologies, Ltd. (KMTS) has a MoatMap StockRank of 21/100 based on Quality (29/100), Value (25/100), and Momentum (52/100) factor scores. The current signal is SELL.

Key Financial Metrics

Price	$21.06
Market Cap	$1.2B
P/E (Forward)	-11.50
Price/Book	5.23
Return on Equity	-56.6%
Return on Invested Capital	-40.2%
Debt/Equity	0.18x
Gross Margin	51.4%
Operating Margin	-137.4%
Revenue Growth	66.2%
Free Cash Flow	$-117M

Kestra Medical Technologies, Ltd. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Kestra Medical Technologies, Ltd.’s (KMTS) StockRank?: MoatMap’s StockRank for Kestra Medical Technologies, Ltd. (KMTS) is 21/100, with a Sell signal. It is a composite of Quality (29), Value (25), and Momentum (52) factor ranks across MoatMap’s 20,000+ stock universe.
Does Kestra Medical Technologies, Ltd. have an economic moat?: Kestra Medical Technologies, Ltd. (KMTS) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Kestra Medical Technologies, Ltd. a buy, hold, or sell?: MoatMap’s current signal for Kestra Medical Technologies, Ltd. (KMTS) is Sell, based on a StockRank of 21/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Kestra Medical Technologies, Ltd. in?: Kestra Medical Technologies, Ltd. (KMTS) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).